Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › D-cycloserine

D-cycloserine

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of D-cycloserine

39 trials tracked of D-cycloserine: 15 in phase 3 or 4.

39Trials tracked
15Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 7 Phase 3 8 Phase 2 13 Phase 1 4 Other / NA 7
  1. Phase 4 Developing Memory Reconsolidation Blockers as Novel Posttraumatic Stress Disorder (PTSD) Treatments Completed
  2. Phase 4 D-Cycloserine Enhancement of Exposure in Social Phobia Completed
  3. Phase 4 Veteran Stress and Learning Study Completed
  4. Phase 4 NMDA Antagonists in Bipolar Depression Completed
  5. Phase 4 Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia Completed
  6. Phase 4 Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia Completed
Show 33 more trials
  1. Phase 4 D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions Completed
  2. Phase 3 Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia Completed
  3. Phase 3 Cognitive Remediation With D-Cycloserine Completed
  4. Phase 3 D-Cycloserine and Social Skills Training in Autism Spectrum Disorders Completed
  5. Phase 3 Trial of D-Cycloserine in Schizophrenia Completed
  6. Phase 3 D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for Acrophobia Completed
  7. Phase 3 D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD Completed
  8. Phase 3 Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism Completed
  9. Phase 3 D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD) Completed
  10. Phase 2 Effect of D-cycloserine on Treatment of Posttraumatic Stress Disorder (PTSD) in Youth Completed
  11. Phase 2 D-cycloserine and Treatment of Feeding Disorders Completed
  12. Phase 2 D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents Completed
  13. Phase 2 Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia Completed
  14. Phase 2 D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals Completed
  15. Phase 2 fMRI Study Examining Effects of D-cycloserine in Specific Phobia Completed
  16. Phase 2 The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly Completed
  17. Phase 2 Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder Completed
  18. Phase 2 D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder Completed
  19. Phase 2 D-cycloserine in the Management of Chronic Low Back Pain Completed
  20. Phase 2 NMDA Receptors in Motor Learning in Humans Completed
  21. Phase 2 Improving Learning-based Treatment of Cocaine Dependence With Medication Completed
  22. Phase 2 D-Cycloserine Facilitation of Cocaine - Cue Extinction Completed
  23. Phase 1 Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder Completed
  24. Phase 1 Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine Completed
  25. Phase 1 Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine Completed
  26. Phase 1 D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder Completed
  27. N/A D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia Completed
  28. N/A Virtual Reality & D-cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD) Completed
  29. N/A Exposure, D-cycloserine Enhancement, and Functional Magnetic Resonance Imaging (fMRI) in Snake Phobics Completed
  30. N/A D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD Completed
  31. N/A A Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD Completed
  32. N/A Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo Completed
  33. N/A 2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD Completed

Showing the 39 most-cited and recently-updated of 39 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.